Abstract
Purpose: to evaluate the effectiveness of correction of eating behaviour disorders, anthropometric, physiological indicators by impFreelementing combined non-drug treatment for patients with non-alcoholic fatty liver disease on the background of abdominal obesity.
Material and methods
85 patients with non-alcoholic fatty liver disease on the background of abdominal obesity of the 1st degree were examined. All patients were divided into two clinical groups: 1st group (research) - 48 people, with average body mass index BMI=32.55±1.07 kg/m2, who underwent a course of cognitive behavioural therapy, diet therapy, and physical activity for 6 months; the control group - 37 people with average BMI=31.95±1.03 kg/m2 followed only a rational diet and physical activity, without cognitive behavioural therapy. The examination of the patients included the measurement of anthropometric and physiological indicators, questionnaires according to the DEBQ (Dutch Eating Behaviour Questionnaire).
Results
On the 180th day, the number of patients with normal blood pressure in the 1st group increased in 2.38 times (D=2.3511, p=0.0015), healthy eating behavior was recorded in 2.38 times more often (D=0.2215, p=0.0047) and the number of restrictive type of EB decreased in 2.0 times (D=0.4321, p=0.0031), compared to the control group.
Conclusion
A combined course of therapy in the form of a rational diet, aerobic exercise and cognitive behavioural therapy should be an integral component of early non-drug treatment, as a guarantee not only of the correction of anthropometric and functional indicators, but also of the modification of the eating behavior and a guarantee of long-term maintenance of the desired weight.
Publisher
Independent publisher Zhanneta Kozina
Subject
Occupational Therapy,Rehabilitation,Education,Physical Therapy, Sports Therapy and Rehabilitation,Orthopedics and Sports Medicine,Complementary and Manual Therapy
Reference25 articles.
1. Caballero B. Humans against Obesity: Who Will Win? Adv Nutr. 2019 Jan 1;10(suppl_1):S4-S9. doi: 10.1093/advances/nmy055. PMID: 30721956; PMCID: PMC6363526.
2. Kiro LS , M. Yu. Zak MY , OV Chernyshov OV , MV Sverdlova MV. Kharchova povedinka ta ozhirinnia: genderno-vikovi osoblivosti. Endocrinology 2021, 26(2): 119-127 (in Ukrainian).
3. Robinson E, Marty L, Higgs S, Jones A. Interoception, eating behavior and body weight. Physiol Behav. 2021 Aug 1;237:113434. doi: 10.1016/j.physbeh.2021.113434. Epub 2021 Apr 24. PMID: 33901529.
4. Poovey K, Ahlich E, Attaway S, Rancourt D. General versus hunger/satiety-specific interoceptive sensitivity in predicting disordered eating. Appetite. 2022 Apr 1;171:105930. doi: 10.1016/j.appet.2022.105930. Epub 2022 Jan 13. PMID: 35033582.
5. Kiro LS , M. Yu. Zak MY , OV Chernyshov OV , MV Sverdlova MV . Nadlishkova weight she ozhirinnia : Chi i.e vzaiemozviazok Z kharchovoiu povedinkoiu? UZhBMS 2021, 6(1): 84-90 (in Ukrainian ).